×

Roche To Launch Short Duration Infusion Gazyvaro For Patients In The EU - Quick Facts

Published Oct 14 2021 at 5:46 AM GMT
Key
Points
  • (RTTNews) - Roche (RHHBY) reported EMA approval of a shorter 90-minute Gazyvaro infusion time, administered in combination with chemotherapy in patients with previously treated or untreated advanced follicular lymphoma.
  • The regular rate of infusion can take approximately three to four hours, the company noted.




Trending

Stats

  • Published Oct 14, 2021 5:46 AM GMT